Ginkgo Bioworks Holdings, Inc. Class A
News
Ginkgo Regains Compliance with NYSE Minimum Bid Price Requirement
PR Newswire Ginkgo Regains Compliance with NYSE Minimum Bid Price Requirement Ginkgo Regains Compliance with NYSE Minimum Bid Price Requirement PR Newswire BOSTON, Sept. 4, 2024 BOSTON, Sept. 4, 2024...\n more…
2 Big Risks and 2 Big Opportunities for Ginkgo Bioworks Stock
Fool.com Headlines When a stock you own is struggling to retain value, it pays to know what new problems might lie awaiting in its future. To have the conviction to retain your shares through a dip, you'll also need to...\n more…
This 1 AI Stock Could Revolutionize Biotech and Pharma
Fool.com Headlines Ginkgo Bioworks (NYSE: DNA) is a biotech that's going big on artificial intelligence (AI). Between its need to perform core workflows with high efficiency, and its generation of tons of biological...\n more…
Pine Valley Investments Ltd Liability Co Grows Stock Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Ticker Report Pine Valley Investments Ltd Liability Co boosted its holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 653.7% during the 2nd quarter, HoldingsChannel.com reports. The...\n more…
Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
PR Newswire Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare...\n more…
Down 88% in 1 Year, What's Next for Ginkgo Bioworks Stock?
Fool.com Headlines Ginkgo Bioworks (NYSE: DNA) stock has had a rough 12 months, falling 88%, and undergoing a reverse stock split on Aug. 20 that left its shares down by around 18% in the aftermath. Depending on which...\n more…